Cargando…

2212 A systematic overview of cost-utility analyses in dermatology

OBJECTIVES/SPECIFIC AIMS: Costs associated with the treatment of skin diseases accounted for greater than 4% of total US healthcare spending in 2013, an increase of $46 billion (170%) since 2004. Considering the increase in novel treatments and spending, cost-utility analyses (CUAs) may provide a be...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, David G., Faletsky, Adam, Neumann, Peter, Cohen, Joshua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799363/
http://dx.doi.org/10.1017/cts.2018.42

Ejemplares similares